Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.
Sep 2011 - Clin. Cancer Res.; 17(17):1078-0432 [PMID:21771874]
[Lesterhuis WJ] [de Vries IJ] [Schreibelt G] [Lambeck AJ] [Aarntzen EH] [Jacobs JF] [Scharenborg NM] [van de Rakt MW] [de Boer AJ] [Croockewit S] [van Rossum MM] [Mus R] [Oyen WJ] [Boerman OC] [Lucas S] [Adema GJ] [Punt CJ] [Figdor CG]

Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment, a phase I/II study in metastatic melanoma patients.
Aug 2010 - :1078-0432 [PMID:20736326]
[Jacobs JF] [Punt CJ] [Lesterhuis WJ] [Sutmuller RP] [Brouwer HM] [Scharenborg NM] [Klasen IS] [Hilbrands LB] [Figdor CG] [de Vries IJ] [Adema GJ]

Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients.
Apr 2009 - Clin. Cancer Res.; 15(7):1078-0432 [PMID:19318472]
[Verdijk P] [Aarntzen EH] [Lesterhuis WJ] [Boullart AC] [Kok E] [van Rossum MM] [Strijk S] [Eijckeler F] [Bonenkamp JJ] [Jacobs JF] [Blokx W] [Vankrieken JH] [Joosten I] [Boerman OC] [Oyen WJ] [Adema G] [Punt CJ] [Figdor CG] [de Vries IJ]

Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model.
Feb 2008 - Int. J. Cancer; 122(8):1097-0215 [PMID:18076066]
[Grauer OM] [Sutmuller RP] [van Maren W] [Jacobs JF] [Bennink E] [Toonen LW] [Nierkens S] [Adema GJ]

Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests.
May 2006 - Ann. Oncol.; 17(6):0923-7534 [PMID:16600979]
[Lesterhuis WJ] [de Vries IJ] [Schuurhuis DH] [Boullart AC] [Jacobs JF] [de Boer AJ] [Scharenborg NM] [Brouwer HM] [van de Rakt MW] [Figdor CG] [Ruers TJ] [Adema GJ] [Punt CJ]